I believe we are getting closer to seeing a significant move. That volume on Friday over 100 million shares was very telling. The shorts crushed it back down, but somebody wanted in and was paying .18 cents for their shares. I know that they have a lot more going on than just the On Target Study results. That I believe is just the spark that will ignite the fire. If we get FDA approval this summer JAGX will be north of $20 per share and potentially even higher. So, there is a lot to be excited about here.